ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

ClinicalTrials.gov ID: NCT00893789

Public ClinicalTrials.gov record NCT00893789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil (50, 150, and 250 mg/Day) as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Study identification

NCT ID
NCT00893789
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon, Inc.
Industry
Enrollment
117 participants

Conditions and interventions

Interventions

  • Armodafinil Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 29, 2009
Primary completion
Jan 30, 2011
Completion
Jan 30, 2011
Last update posted
Dec 16, 2021

2009 – 2011

United States locations

U.S. sites
68
U.S. states
29
U.S. cities
56
Facility City State ZIP Site status
Teva Investigational Site 58 Birmingham Alabama 35213
Teva Investigational Site 62 Tucson Arizona 85712
Teva Investigational Site 40 Tucson Arizona 85723
Teva Investigational Site 16 Hot Springs Arkansas 71913
Teva Investigational Site 5 Little Rock Arkansas 72205
Teva Investigational Site 44 Fountain Valley California 92708
Teva Investigational Site 49 La Palma California 90623
Teva Investigational Site 51 La Palma California 90623
Teva Investigational Site 71 Mather California 95655
Teva Investigational Site 55 San Diego California 92103
Teva Investigational Site 33 San Diego California 92161
Teva Investigational Site 53 Santa Monica California 90404
Teva Investigational Site 69 Wallingford Connecticut 06492
Teva Investigational Site 52 Hallandale Florida 33009
Teva Investigational Site 47 Miami Florida 33173
Teva Investigational Site 1 Orlando Florida 32806
Teva Investigational Site 18 Pembroke Pines Florida 33026
Teva Investigational Site 10 Spring Hill Florida 34609
Teva Investigational Site 38 St. Petersburg Florida 33707
Teva Investigational Site 17 Tampa Florida 33607
Teva Investigational Site 26 Atlanta Georgia 30321
Teva Investigational Site 12 Atlanta Georgia 30342
Teva Investigational Site 14 Atlanta Georgia 30342
Teva Investigational Site 68 Gainesville Georgia 30501
Teva Investigational Site 67 Macon Georgia 31201
Teva Investigational Site 29 Stockbridge Georgia 30281
Teva Investigational Site 15 Suwanee Georgia 30024
Teva Investigational Site 46 Chicago Illinois 60675-6714
Teva Investigational Site 54 Chicago Illinois 60675-6714
Teva Investigational Site 59 Chicago Illinois 60675-6714
Teva Investigational Site 28 Danville Indiana 46122
Teva Investigational Site 19 Fort Wayne Indiana 46805
Teva Investigational Site 2 Indianapolis Indiana 46250
Teva Investigational Site 39 Indianapolis Indiana 46260
Teva Investigational Site 41 Iowa City Iowa 52242
Teva Investigational Site 9 Shawnee Mission Kansas 66201
Teva Investigational Site 48 Louisville Kentucky 40217
Teva Investigational Site 32 Chevy Chase Maryland 20815-6901
Teva Investigational Site 37 Belmont Massachusetts 02478
Teva Investigational Site 70 Brighton Massachusetts 02135
Teva Investigational Site 22 Saginaw Michigan 48604
Teva Investigational Site 7 Hattiesburg Mississippi 39402
Teva Investigational Site 42 St Louis Missouri 63143
Teva Investigational Site 56 Lincoln Nebraska 68510
Teva Investigational Site 72 New York New York 10010
Teva Investigational Site 63 New York New York 10019
Teva Investigational Site 36 West Seneca New York 14224
Teva Investigational Site 11 Durham North Carolina 27710
Teva Investigational Site 45 Winston-Salem North Carolina 27157
Teva Investigational Site 31 Cincinnati Ohio 45227
Teva Investigational Site 34 Cincinnati Ohio 45246
Teva Investigational Site 57 Middleburg Heights Ohio 44130
Teva Investigational Site 30 Toledo Ohio 43623
Teva Investigational Site 3 Oklahoma City Oklahoma 73112
Teva Investigational Site 64 Clarks Summit Pennsylvania 18411
Teva Investigational Site 13 Jefferson Hills Pennsylvania 15025
Teva Investigational Site 65 Columbia South Carolina 29201
Teva Investigational Site 61 Germantown Tennessee 38139
Teva Investigational Site 60 Austin Texas 78756
Teva Investigational Site 25 Dallas Texas 75235
Teva Investigational Site 8 Houston Texas 77030
Teva Investigational Site 20 Houston Texas 77063
Teva Investigational Site 73 Kingwood Texas 77339
Teva Investigational Site 23 San Antonio Texas 78229
Teva Investigational Site 35 Midvale Utah 84047
Teva Investigational Site 66 Midvale Utah 84047
Teva Investigational Site 24 Richmond Virginia 23249
Teva Investigational Site 50 West Allis Wisconsin 53227

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00893789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2021 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00893789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →